HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 57.60
Day range
kr 56.00 - kr 58.00
Year range
kr 46.55 - kr 108.80
Market cap
1.69B SEK
Avg Volume
34.46K
P/E ratio
57.56
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 118.90M | 28.93% |
Operating expense | 30.77M | 34.36% |
Net income | 9.79M | -2.72% |
Net profit margin | 8.23 | -24.56% |
Earnings per share | 0.33 | — |
EBITDA | 24.84M | 43.41% |
Effective tax rate | 20.60% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 72.67M | 367.14% |
Total assets | 813.54M | 76.55% |
Total liabilities | 543.76M | 115.05% |
Total equity | 269.78M | — |
Shares outstanding | 29.53M | — |
Price to book | 6.30 | — |
Return on assets | 5.96% | — |
Return on capital | 6.90% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 9.79M | -2.72% |
Cash from operations | 13.44M | 76.44% |
Cash from investing | -11.87M | 6.39% |
Cash from financing | -7.16M | -181.46% |
Net change in cash | -5.59M | -250.04% |
Free cash flow | 3.58M | 134.96% |
About
Founded
2006
Website
Employees
55
